+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 65Years
All Genders
ID07889999

Observational Study of MASLD Characteristics and Ursosan Use in Adults in Kazakhstan Including a 6-Month Follow-Up in Almaty

Led by Kazakh Association of Internal Medicine Specialists · Updated on 2026-10-22

420

Participants Needed

7

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adults in Kazakhstan who have metabolic dysfunction-associated steatotic liver disease MASLD to better understand how this liver condition appears and is managed in everyday medical care. The study includes about 420 adults with MASLD, focusing on their health characteristics and how the disease affects them. A smaller group of about 65 participants in Almaty, who were already prescribed Ursosan by their doctors, will be followed to observe changes in liver-related health measures. The study has two parts a cross-sectional component where information from medical records, lab tests, liver imaging, and questionnaires is collected once for each participant and a prospective cohort component that follows the subgroup receiving Ursosan for approximately six months. During this follow-up, participants will have remote contacts at about 2 and 4 months and a final assessment at 6 months. Treatment decisions, including the use of Ursosan, are made by the participants doctors as part of routine care, not assigned by the study. Participants will provide data through routine medical care records, imaging scans, laboratory tests, and questionnaires about lifestyle and health. Researchers will measure liver health through imaging, liver enzyme levels, and fibrosis assessments. The study monitors changes in these measures over time, especially in the Ursosan subgroup. Participation may last up to six months for some, while others contribute data at a single time point, helping researchers understand MASLD and responses to Ursosan in real-world settings.

CONDITIONS

Brief Title

Clinical Profile of Patients With MASLD in Kazakhstan and Clinical Effectiveness of Ursosan in Almaty

Research Team

A

Almagul Dzhumabayeva, Gastroenterologist

G

Gleb Plotnikov, CRA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here